Abstract. Myelodysplastic syndromes are clonal stem cell disorders and are characterized by a mostly hypercellular bone marrow with insufficient, dysplastic hematopoiesis. In ...
Abstract. Even in the area of molecular medicine, the diagnosis of myelodysplastic syndromes (MDS) is based on the morphological evaluation of the bone marrow and the analysis of ...
Abstract. The myelodysplastic syndromes (MDS) represent a heterogeneous group of diseases affecting the hematopoietic stem cells, which are characterized by reduced blood ...
Abstract. In the next years the role of molecular genetics will increase in diagnosis, prognosis and therapy of MDS. In the treatment of low risk MDS anemia remains the biggest ...